Shelton Capital Management trimmed its holdings in Agilent Technologies Inc (NYSE:A) by 56.5% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 5,323 shares of the medical research company’s stock after selling 6,900 shares during the period. Shelton Capital Management’s holdings in Agilent Technologies were worth $356,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the company. Dupont Capital Management Corp purchased a new position in Agilent Technologies during the third quarter worth about $101,000. Front Row Advisors LLC purchased a new position in Agilent Technologies during the fourth quarter worth about $106,000. Prudential PLC purchased a new position in Agilent Technologies during the second quarter worth about $211,000. Steward Partners Investment Advisory LLC purchased a new position in Agilent Technologies during the third quarter worth about $213,000. Finally, Cannell Peter B & Co. Inc. purchased a new position in Agilent Technologies during the third quarter worth about $215,000.

Several research firms recently issued reports on A. Morgan Stanley reissued an “overweight” rating on shares of Agilent Technologies in a report on Tuesday, November 14th. Zacks Investment Research cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Thursday, November 16th. ValuEngine cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Robert W. Baird reaffirmed a “buy” rating and issued a $72.00 target price on shares of Agilent Technologies in a report on Friday, November 24th. Finally, Barclays increased their target price on shares of Agilent Technologies from $67.00 to $71.00 and gave the company an “overweight” rating in a report on Tuesday, November 21st. Six investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $69.25.

In other news, insider Patrick Kaltenbach sold 7,358 shares of the stock in a transaction that occurred on Wednesday, November 22nd. The shares were sold at an average price of $69.28, for a total value of $509,762.24. Following the sale, the insider now directly owns 72,862 shares in the company, valued at $5,047,879.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Michael R. Mcmullen sold 22,481 shares of the stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $68.77, for a total transaction of $1,546,018.37. Following the completion of the sale, the chief executive officer now owns 336,637 shares in the company, valued at $23,150,526.49. The disclosure for this sale can be found here. Insiders sold 219,991 shares of company stock worth $15,468,795 over the last quarter.

Agilent Technologies Inc (NYSE A) opened at $66.98 on Friday. Agilent Technologies Inc has a 1-year low of $50.02 and a 1-year high of $75.00. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.30 and a quick ratio of 2.85. The stock has a market cap of $21,635.75, a PE ratio of 31.90, a price-to-earnings-growth ratio of 2.02 and a beta of 1.28.

Agilent Technologies (NYSE:A) last issued its earnings results on Monday, November 20th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.62 by $0.05. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.95%. The company had revenue of $1.19 billion during the quarter, compared to analysts’ expectations of $1.17 billion. During the same period last year, the company posted $0.59 earnings per share. The firm’s quarterly revenue was up 7.0% compared to the same quarter last year. equities research analysts anticipate that Agilent Technologies Inc will post 2.58 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd were given a $0.149 dividend. The ex-dividend date was Friday, December 29th. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.13. This represents a $0.60 annualized dividend and a dividend yield of 0.89%. Agilent Technologies’s dividend payout ratio is currently 28.57%.

TRADEMARK VIOLATION NOTICE: This article was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this article on another website, it was illegally copied and republished in violation of U.S. and international copyright and trademark law. The original version of this article can be accessed at https://www.watchlistnews.com/shelton-capital-management-trims-stake-in-agilent-technologies-inc-a/1859423.html.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.